Dosing schedule for erbB2 anticancer agents

Details for Australian Patent Application No. 2004264726 (hide)

Owner Pfizer Products Inc.

Inventors Connell, Richard Damian; Jani, Jitesh Pranlal; Moyer, James Dale; Steyn, Stefanus Johannes; Noe, Dennis Alan; Bhattacharya, Samit Kumar

Agent Shelston IP

Pub. Number AU-A-2004264726

PCT Pub. Number WO2005/016347

Priority 60/495,919 18.08.03 US

Filing date 6 August 2004

Wipo publication date 24 February 2005

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/00 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016347 Priority application(s): WO2005/016347

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264730-Process for preparing a food product using depolymerised pectin as stabiliser

2004264724-Piperazine derivatives for the treatment of HIV infections